Brazil Cannabis & Hemp News

03/26/2020 - 4:07pm
RAMM Pharma Corp. Receives Federal Approval and Registration of XALEX™ 10 (cannabidiol) Oral Solution
(Argentina, Brazil, Cannabis, CBD, Development, Distribution, Events, Growing, Investing, Law, Management, Manufacturing, Paraguay, Peru, Product Development, Production, Products, Recreational, Regulations, Subsidiaries, Testing, United States, Uruguay, THC, Recreational Cannabis, Pharmaceuticals, Cultivation) RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or “RAMM”) (CSE: RAMM ), a leader in plant-derived cannabinoid pharmaceutical products, is pleased to announce that the Uruguayan Ministry of Public Health, (Ministerio de Salúd Publica or “MSP”) has approved and registered XALEX 10 (cannabidiol) oral solution, a prescription pharmaceutical formulation of highly-purified, plant-derived cannabidiol (CBD) free of tetrahydrocannabinol (THC), for the treatment of refractory epilepsy. RAMM has also been granted a license expansion and approval by the Instituto de Regulación y Control de Cannabis (“IRCCA”) for additional proprietary cannabis-based products and to include certain products for veterinary use, further expanding the Company’s robust portfolio of product offerings to the Latin American market. “The approval of XALEX 10 is a significant accomplishment for RAMM Pharma, offering patients another federally approved pharmaceutical CBD medicine,” stated Jack...
https://investingnews.com/daily/cannabis-investing/ramm-pharma-corp.receives-fed…
03/26/2020 - 9:12am
MJNA
 Medical Marijuana, Inc. (MJNA) CEO Featured in Reuters Coverage Highlighting the Impact of COVID-19
(Argentina, Brazil, California, Canada, Cannabis, CBD, Development, Events, Food, Hemp, Investment, Investments, Investors, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, New York, Paraguay, Products, Research, Stocks, United States, Industrial Hemp, Pharmaceuticals) Medical Marijuana, Inc. CEO Featured in Reuters Coverage Highlighting the Impact of COVID-19 on Cannabis Industry Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company’s CEO Dr. Stuart Titus was featured in global financial news outlet Reuters discussing the impact of COVID-19 on the cannabis industry. The March 25, 2020, Reuters article entitled “As customers hoard pot brownies, North American weed firms see lockdown boost,” provided coverage of a recent surge in cannabis sales during the COVID-19 pandemic and quoted Titus as saying: “We have seen stockpiling in Canada by consumers who have snapped up products from LPs (licensed producers).” According to the article, cannabis retailers in both the U.S. and Canada are seeing a sharp increase in sales, including a 50 percent spike...
https://marijuanastocks.com/mjna-ceo-featured-in-reuters-coverage-highlighting-t…
03/26/2020 - 2:24am
AXIM, MJNA
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Completes Acquisition of Oncology Research and Development Company Sapphire Biotech, Inc.
(Acquisition, Argentina, AXIM, AXIM Biotechnologies, Brazil, Cannabis, CBD, Delivery Systems, Development, Hemp, Investment, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Monitoring, Paraguay, Products, Research, United States, Industrial Hemp, Patents, Pharmaceuticals, Intellectual Property) SAN DIEGO, March 24, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company AXIM ® Biotechnologies, Inc . (OTCQB: AXIM) (“AXIM® Biotech” or “AXIM”) has completed the acquisition of leading oncology research and development company Sapphire Biotech, Inc. (“Sapphire”). In January of this year, AXIM announced that the Company signed a binding term sheet to acquire Sapphire. As part of the acquisition, AXIM has acquired 100 percent of the capital stock of Sapphire and will operate Sapphire as a wholly-owned subsidiary. Sapphire will continue to be led by Catalina Valencia as Chief Executive Officer. Ms. Valencia has stewarded Sapphire in the development of its unique patent-pending pipeline. “Sapphire Biotech has already proven itself to have great potential...
https://cannabislaw.report/medical-marijuana-inc-investment-company-axim-biotech…
03/25/2020 - 9:00am
It Takes The Village
(Argentina, Banking, Bar, Brazil, California, Cannabis, CBD, Facilities, Genetics, Grower, Growing, Medical Marijuana, Regulations, Spain, Strains, Testing, United States, Lights, Dispensaries, Extracts, Cultivation) When people talk about California’s legendary cannabis, they frequently mention growing ganja grown deep in the Emerald Triangle and weed sparked up on the bustling streets of Los Angeles and San Francisco. But there’s another region in the Golden State that is now demanding attention. Since California’s adult-use cannabis market came online in 2018, Sacramento has exploded onto the scene as a hub of top-shelf indoor cultivation. Few people in town — perhaps only Gov. Gavin Newsom — have helped push Sacramento to the top of the cannabis stratosphere more than its cultivators, who are growing some of the best cannabis in the world. But in recent years, one local cultivator has pushed the envelope so far that everyone else in town (and across the state) is now growing the genetics he’s helped curate and breed. As half of Symbiotic Genetics , The Village finds himself among a small group of cultivators giving Sacramento’s cannabis a global reach. At one point, there was so much of his...
https://cannabisnow.com/it-takes-the-village/
03/24/2020 - 6:20pm
Nappy Dread
(Brazil, California, Cannabis, Growing, Hemp, Netherlands, Organic, Products, Research, Training, United States) With a new cannabis renaissance dawning, more and more people are making moves to put the plant front and center as a way to build a more sustainable and just future. Meanwhile, an estimated 27.4 billion disposable diapers end up in landfills across America annually (according to the folks at RealDiaper.org). Clearly, it was only a matter of time before the worlds of pot and poop collided. Enter Billie Wonder , a Dutch retailer providing eco-friendly and adorable washable diapers and training pants to the masses made from green materials such as organic cotton, bamboo and yes, hemp. The company features both an online shop and brick and mortar showroom in Amsterdam , and is aiming to spread awareness of the benefits of reusable diapers while simultaneously working towards creating the world’s first nappy made completely from cannabis. “I think hemp is the plant of the future in many, many ways, but also when it comes to diapers,” explains Amsterdam native Steef Fleur, co-founder of...
https://cannabisnow.com/nappy-dread/
03/24/2020 - 2:00pm
Budweiser and Hennessy Makers Are Donating Tons of Booze to Make Hand Sanitizer
(Alcohol, Australia, Brazil, Connecticut, Containers, Growing, India, Italy, Kenya, Manufacturer, Oregon, Products, United States) On Monday, Anheuser-Busch InBev and Diageo, the makers of Budweiser beer and Hennessy cognac, respectively, joined forces to donate millions of liters of alcohol — or over 700 tons — around the world for crafting disinfectants and hand sanitizers. Commercial sanitizers have become rare, valuable commodities during the coronavirus pandemic — especially in the US, where Americans continue to panic-buy and hoard supplies in preparation for the viral outbreak to get worse. “This is the quickest and most effective way for us to meet the surging demand for hand sanitizer around the world,” Diageo CEO Ivan Menezes said in a statement, according to Reuters . The latest partnership of party suppliers indicates that private enterprises are stepping up to address shortcomings that governments still have yet to resolve. Anheuser-Busch, headquartered in the US, is the world’s largest beer manufacturer. The company produces Beck’s, Stella Artois, Bass Pale Ale, Busch Beer, Michelob, and Natural...
https://merryjane.com/news/budweiser-and-hennessy-makers-are-donating-tons-of-bo…
03/24/2020 - 12:58pm
AXIM, MJNA
Medical Marijuana, Inc. (MJNA) Completes Acquisition of Oncology Research and Development Company Sapphire Biotech, Inc.
(Acquisition, Argentina, AXIM, AXIM Biotechnologies, Brazil, California, Cannabis, CBD, Delivery Systems, Development, Events, Food, Hemp, Investment, Investments, Investors, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Monitoring, Paraguay, Products, Research, Stocks, United States, Industrial Hemp, Patents, Pharmaceuticals, Intellectual Property) Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Completes Acquisition of Oncology Research and Development Company Sapphire Biotech, Inc. Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech” or “AXIM”) has completed the acquisition of leading oncology research and development company Sapphire Biotech, Inc. (“Sapphire”). In January of this year, AXIM announced that the Company signed a binding term sheet to acquire Sapphire. As part of the acquisition, AXIM has acquired 100 percent of the capital stock of Sapphire and will operate Sapphire as a wholly-owned subsidiary. Sapphire will continue to be led by Catalina Valencia as Chief Executive Officer. Ms. Valencia has stewarded Sapphire in the...
https://marijuanastocks.com/mjna-completes-acquisition-of-oncology-research-and-…
03/19/2020 - 9:20am
MJNA
Medical Marijuana, Inc. (MJNA) Receives Patent in Australia for Its Novel Monotherapeutic Compounds
(Argentina, Australia, Biotechnology, Brazil, California, Canada, Cannabis, CBD, Development, Events, Food, Hemp, India, Investment, Investments, Investors, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Paraguay, Pennsylvania, Products, Research, Stocks, United States, Industrial Hemp, Patents, Pharmaceuticals, Intellectual Property) Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Receives Patent in Australia for Its Novel Monotherapeutic Compounds to Treat CNS and PNS Disorders Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its portfolio investment company Kannalife, Inc. (“Kannalife”) (OTCQB: KLFE) has been issued Australian Patent AU2015204609B2 (the “Patent”) specific to “Novel Functionalized 1,3-Benzene Diols and their Method of Use for the Treatment of Hepatic Encephalopathy.” With this Patent, Kannalife now holds seven patents across the globe. “Medical Marijuana, Inc. and our portfolio of companies such as Kannalife are committed to widening knowledge and acceptance of cannabis and cannabinoid-related studies around the world,” said Dr. Stuart Titus, CEO of Medical Marijuana, Inc. “...
https://marijuanastocks.com/mjna-receives-patent-in-australia-for-its-novel-mono…
03/17/2020 - 9:35am
MJNA
Medical Marijuana, Inc. (MJNA) Becomes First Company to Legally Import CBD Products Into Russia
(Argentina, Brazil, Bulgaria, California, Cannabis, CBD, Development, Education, Events, Food, Hemp, Investment, Investments, Investors, Kazakhstan, Kyrgyzstan, Marketing, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Oils, Paraguay, Products, Research, Russia, Stocks, United States, Industrial Hemp, Pharmaceuticals) Medical Marijuana, Inc. Subsidiary Kannaway® Becomes First Company to Legally Import CBD Products Into Russia Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that its subsidiary Kannaway® has been granted Russia’s first-ever certificate to legally import cannabidiol (CBD) products into the country. According to the certificate, Kannaway® “is the first company in the Russian Federation to have cannabidiol in its products.” This certification allows Kannaway® to import its wide range of CBD products into the country, including the Company’s popular tinctures, oils, skincare products and more. “We have achieved a huge milestone for both Kannaway and Russia with this certificate,” said Kannaway® CEO Blake Schroeder. “No other CBD products have legally been imported and sold to Russian consumers...
https://marijuanastocks.com/mjna-becomes-first-company-to-legally-import-cbd-pro…
03/14/2020 - 6:08am
MJNA
Medical Marijuana, Inc. Portfolio of Companies Celebrates $2 Million Milestone in CBD Product Donations to Non-Profit Organization ECHO Connection
(Argentina, Brazil, California, Cannabis, CBD, Development, Education, Events, Food, Hemp, Investment, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Paraguay, Products, Research, United States, Industrial Hemp, Pharmaceuticals) SAN DIEGO, March 12, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that its portfolio of companies, including HempMeds® and Kannaway® , has officially donated $2 million in cannabidiol (CBD) products to ECHO Connection since 2017. ECHO Connection is a non-profit organization that aims to educate and support those pursuing cannabinoids for their therapeutic benefits in a trustworthy, safe environment. The organization strives to offer charitable support to ease the burden on families of children with disabilities or special needs. Additionally, ECHO connects families in need with doctors that can help them through an individualized comprehensive approach consisting of education and collaboration. “While CBD has become an emerging and accelerating market in the overall ‘...
https://cannabislaw.report/medical-marijuana-inc-portfolio-of-companies-celebrat…
03/13/2020 - 10:25am
Cannabis Helps Improve Quality of Life for Chronically Ill Patients, Study Says
(Brazil, Cannabis, Medical Marijuana, Research, Spain, Pharmaceuticals) By definition, living life with a chronic illness is full of constant pain, uncomfortability, and uncertainty. But for patients living with incurable ailments like HIV or epilepsy, there is one thing that can improve day-to-day life even more than some pharmaceuticals: cannabis. According to a new research paper published in the latest issue of Phytotherapy Research , scientists in Spain and Brazil tracked quality of life status of chronically ill patients in 4, 8, and 12 month increments. To see if marijuana had any affect on the lived experience of their ailments , researchers observed and recorded updates as 90 percent of the test group self-medicated with cannabis daily. Once the longitudinal time frame was complete, researchers compared patient reports during daily cannabis use to their status before picking up pot, and discovered a significant effect. "Mid-term use of medical cannabis seems to show adequate tolerability regarding cognitive and psychopathological abilities, and...
https://merryjane.com/news/cannabis-helps-improve-quality-of-life-for-chronicall…
03/12/2020 - 1:59pm
After 6 Months, 83% of Ayahuasca Users Report Improved Mental Health, Study Says
(Brazil, Exploring, Growing, Research, Spain, Pharmaceuticals) A new observational study found that the vast majority of ayahuasca users report significant reductions in depression and other mental health issues. The new study, published in the Scientific Reports journal , includes two different sub-studies exploring the short- and long-term effects of ayahuasca use. In the first sub-study, researchers from Spain and Brazil administered a psychiatric interview and a number of questionnaires to 40 subjects who never used ayahuasca before, but planned to do so. The interview and questionnaires were given to subjects before their first trip, and then repeated in two follow-up visits one and six months after the subjects' initial trip. The majority of these subjects were from Spain, where many small community groups have recently begun holding ayahuasca ceremonies. Just over half of these subjects were college graduates, and 84 percent were atheists. Over 59 percent of the subjects said they were trying ayahuasca for therapeutic reasons, while nearly...
https://merryjane.com/health/after-6-months-83-of-ayahuasca-users-report-improve…
03/12/2020 - 10:22am
MJNA
Medical Marijuana, Inc. (MJNA) Portfolio of Companies Celebrates $2 Million Milestone in CBD Product Donations
(Argentina, Brazil, California, Cannabis, CBD, Development, Education, Events, Food, Hemp, Investment, Investments, Investors, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Paraguay, Products, Research, Stocks, United States, Industrial Hemp, Pharmaceuticals) Medical Marijuana, Inc. Portfolio of Companies Celebrates $2 Million Milestone in CBD Product Donations to Non-Profit Organization ECHO Connection Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that its portfolio of companies, including HempMeds® and Kannaway®, has officially donated $2 million in cannabidiol (CBD) products to ECHO Connection since 2017. ECHO Connection is a non-profit organization that aims to educate and support those pursuing cannabinoids for their therapeutic benefits in a trustworthy, safe environment. The organization strives to offer charitable support to ease the burden on families of children with disabilities or special needs. Additionally, ECHO connects families in need with doctors that can help them through an individualized comprehensive approach consisting of...
https://marijuanastocks.com/mjna-portfolio-of-companies-celebrates-2-million-mil…
03/09/2020 - 12:30pm
Opinion: Brazil Can Lead The World In The Production Of Medical Cannabis
(Brazil, Cannabis, Medical Marijuana, Production) Anvisa paves the way for the Brazilian Congress to create a regulatory framework for medical cannabis. Brazil joins a group of 47 countries, including ...
https://www.benzinga.com/markets/cannabis/20/03/15509305/opinion-brazil-can-lead…
03/09/2020 - 12:26pm
Opinion: Brazil Can Lead The World In The Production Of Medical Cannabis - Benzinga
(Brazil, Cannabis, Medical Marijuana, Production) Opinion: Brazil Can Lead The World In The Production Of Medical Cannabis Benzinga
https://www.benzinga.com/markets/cannabis/20/03/15509305/opinion-brazil-can-lead…
03/09/2020 - 9:36am
Kemin Industries To Distribute Cannabinoid-Containing Drugs In Brazil - Benzinga
(Brazil) Kemin Industries To Distribute Cannabinoid-Containing Drugs In Brazil Benzinga
https://www.benzinga.com/markets/cannabis/20/03/15499784/kemin-industries-to-dis…
03/09/2020 - 3:00am
Kemin Industries To Distribute Cannabinoid-Containing Drugs In Brazil - Yahoo Finance
(Brazil) Kemin Industries To Distribute Cannabinoid-Containing Drugs In Brazil Yahoo Finance
https://finance.yahoo.com/news/kemin-industries-distribute-cannabinoid-containin…
03/06/2020 - 10:59am
MJNA
Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Receives Patent in the European Union (EU)
(Argentina, Australia, Biotechnology, Brazil, California, Canada, Cannabis, CBD, Development, Events, Food, France, Germany, Growing, Hemp, India, Investment, Investors, Italy, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Paraguay, Pennsylvania, Products, Research, Spain, United Kingdom, United States, Industrial Hemp, Patents, Pharmaceuticals, Intellectual Property) SAN DIEGO, March 5, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the European Patent Office has issued European Patent EP3094318B1 (the “Patent”) specific to “Novel Functionalized 1,3-Benzene Diols and their Method of Use for the Treatment of Hepatic Encephalopathy” to its portfolio investment company Kannalife, Inc. (“Kannalife”) (OTCQB: KLFE). This is the sixth patent grant that Kannalife has received. Kannalife will utilize the patent to further explore the application and potential of new molecular entities (NMEs) across epilepsy, neuropathic pain, traumatic head injury, stroke, Chronic Traumatic Encephalopathy (CTE), Post Cardiac Arrest Hypoxic Ischemic Encephalopathy, Epileptic Encephalopathy, and neurodegenerative diseases such as Parkinson’s disease, Alzheimer...
https://cannabislaw.report/medical-marijuana-inc-portfolio-investment-company-ka…
03/01/2020 - 10:22pm
Khiron is First Company Authorized to Extract High THC Medical Cannabis in Colombia
(Brazil, Cannabis, CBD, Colombia, Compliance, Distribution, Edibles, Education, Events, Growing, Investing, Law, Manufacture, Manufacturing, Medical Marijuana, Mexico, Oils, Peru, Production, Products, Regulations, Regulatory Compliance, Testing, United States, Uruguay, Vertically Integrated, THC, Cultivation) Further to cultivation quotas announced on February 26, 2020, this authorization by the Colombian Technical Quotas Authority (“TQG”) allows the Company to now produce oils for sale both domestically and abroad. Of the 9.3 tonnes approved, 50% are for Colombian domestic use and 50% are allowed for export purposes. Export quotas allow for the manufacture of whole plant extract for international purposes to countries such as Peru, Uruguay and Brazil, thereby accessing to a medical cannabis market of $1.4 Billion. (Source: New Frontier Data) Domestic quotas represent a further milestone in the Company’s stated timeline to bring the first medical cannabis products to market in Colombia, targeting patients with two priority conditions; chronic pain and nausea associated with chemotherapy. Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN , OTCQB: KHRNF, Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, today announced that...
https://investingnews.com/daily/cannabis-investing/khiron-is-first-company-autho…
02/27/2020 - 10:51am
MJNA
 Medical Marijuana, Inc. (MJNA) Subsidiary of Medical Marijuana, Inc., Launches New High-Potency CBD Formulation
(Argentina, Brazil, California, Cannabis, CBD, Development, Distributor, Events, Food, Hemp, Investment, Investments, Investors, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Paraguay, Products, Research, Stocks, United States, Industrial Hemp, Pharmaceuticals) HempMeds®, Subsidiary of Medical Marijuana, Inc., Launches New High-Potency CBD Formulation of Its Active Relief Roll-On Topical Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that it has launched a new high-cannabidiol (CBD) formulation of its popular Active Relief Roll-On topical product. “In addition to their many potential wellness benefits, topical CBD products have expanded the world’s acceptance of hemp and cannabinoids,” said Dr. Stuart Titus, CEO of Medical Marijuana, Inc. “People have a general understanding that applying a lotion isn’t going to get you high or impact your cognitive function, they’re more willing to try CBD topical products than something they might have to take orally and from there may become curious to learn what it really is and does.” HempMeds® Active Relief Roll...
https://marijuanastocks.com/mjna-subsidiary-of-medical-marijuana-inc-launches-ne…
02/26/2020 - 11:57am
MJNA
Medical Marijuana, Inc Subsidiary HempMeds Brasil Sponsors Autism Event At Rice University In Houston
(Brazil, California, Cannabis, Events, Medical Marijuana, Medical Marijuana Inc, MJNA, Products, United States) CALIFORNIA: Medical Marijuana, Inc., the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds Brasil, in partnership with the Consulate General of Brazil in Houston, sponsored “Autism Together We Are Stronger” at Rice University on February 22. “We see events like this one as prime opportunities to Read the full article...
https://mjnewsnetwork.com/events/medical-marijuana-inc-subsidiary-hempmeds-brasi…
02/25/2020 - 9:30am
MJNA
 Medical Marijuana, Inc. (MJNA) Subsidiary HempMeds® Brasil Sponsors Autism Event
(Argentina, Brazil, California, Cannabis, CBD, Development, Education, Events, Food, Hemp, Investment, Investments, Investors, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Paraguay, Products, Research, Stocks, United States, Industrial Hemp, Pharmaceuticals) Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Sponsors Autism Event at Rice University in Houston Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® Brasil, in partnership with the Consulate General of Brazil in Houston, sponsored “Autism Together We Are Stronger” at Rice University on February 22. “We see events like this one as prime opportunities to educate people on what cannabidiol, or CBD, is and its potential benefits,” said HempMeds® Brasil Vice President Caroline Heinz. “CBD can be legally imported in Brazil and is even subsidized by the Brazilian government for many indications including autism. We want to do everything we can to help bring awareness to current research that is being conducted on how CBD can be used by people around the world.” In...
https://marijuanastocks.com/mjna-subsidiary-hempmeds-brasil-sponsors-autism-even…
02/24/2020 - 3:48am
ANVISA Authorizes Khiron Life Sciences Corp (OTCMKTS:KHRNF) To Import Medical Cannabis Products Into Brazil From Colombia
(Brazil, Cannabis, CBD, Colombia, Cosmeceuticals, Development, Distribution, Manufacture, Medical Marijuana, Medical Marijuana Inc, Peru, Production, Products) Brazilian Health Regulatory Agency (ANVISA) has authorized Khiron Life Sciences Corp (OTCMKTS:KHRNF) to import medical cannabis products on an individual patient basis. Khiron can now apply for a license to export medical cannabis products to Brazil with this authorization. The company also needs the nod of TSX for the commercialization of cannabis in Brazil. Khiron achieves a milestone Director and Chief Executive Officer of Khiron, Alvaro Torres, said the company achieved another milestone on receiving the regulatory nod from ANVISA to introduce its medical cannabis products in the largest Latin American market. It allows the company to serve the patient population in that region. He further said Khiron work towards achieving authorizations in Peru and Colombia and improves its network in Brazil. A regulatory framework to import medical cannabis ANVISA has established a regulatory framework that involves a comprehensive procedure for the production and importing the medical cannabis...
https://mmjreporter.com/anvisa-authorizes-khiron-life-sciences-corp-otcmktskhrnf…
02/20/2020 - 9:31am
MJNA
 Medical Marijuana, Inc. (MJNA) Portfolio Investment Company Kannalife, Inc. Strengthens Intellectual Property Portfolio
(Argentina, Biotechnology, Brazil, California, Cannabis, CBD, China, Development, Events, Food, Hemp, Investment, Investments, Investors, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Paraguay, Pennsylvania, Production, Products, Research, Stocks, United States, Industrial Hemp, Patents, Pharmaceuticals, Intellectual Property) Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Strengthens Intellectual Property Portfolio with New Chinese-Issued Patent Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that China has issued Chinese Patent CN106456573B (the “Patent”) specific to “Novel Functionalized 1,3-Benzene Diols and their Method of Use for the Treatment of Hepatic Encephalopathy” to its portfolio investment company Kannalife, Inc. (“Kannalife”) (OTC: KLFE). The Patent strengthens Kannalife’s patent portfolio of cannabidiol (CBD)-like molecules. Kannalife’s intellectual property estate of CBD-like molecules (“KLS Family”), which is led by KLS-13019, are capable of acting as neuroprotective agents and have the potential to reverse chemotherapy induced neuropathic pain. Under the Patent, Kannalife will...
https://marijuanastocks.com/mjna-portfolio-investment-company-kannalife-inc-stre…
02/18/2020 - 10:57am
MJNA
Medical Marijuana, Inc. (MJNA) Appoints Squar Milner LLP as New Independent Auditor
(Argentina, Brazil, California, Cannabis, CBD, Consulting, Consulting Services, Development, Events, Food, Hemp, Investment, Investments, Investors, Management, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Paraguay, Products, Research, Stocks, United States, Industrial Hemp, Pharmaceuticals) Medical Marijuana, Inc. Appoints Squar Milner LLP as New Independent Auditor Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), announced today that it has appointed Squar Milner LLP (“Squar Milner”) as the Company’s new independent registered public accounting firm. Squar Milner will begin work immediately on the audit of Medical Marijuana, Inc.’s December 31, 2019 consolidated balance sheet. “After a thorough selection process, we are delighted to welcome Squar Milner as our independent auditor. The firm’s experience auditing companies that that are publicly listed in the U.S. offers us a wealth of talent, expertise and resources,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We look forward to seeing our 2019 audit that Squar Milner is currently working on and plan to maintain a long-term relationship with them.” Squar Milner is one of the nation’s top 50 largest accounting firms, as well as one of the largest independent accounting and advisory firms in California. They...
https://marijuanastocks.com/mjna-appoints-squar-milner-llp-as-new-independent-au…
02/18/2020 - 6:00am
AXIM, HEXO, OTC:HEMP, ACB, ACRGF, CBCA, TRTC, APHA, MJNA, CGC, CVSI, SLNG, ITHUF, KERN, KSHB, NEPT, SMG, STRRF
2020 Top 11 Most Effective Cannabis PR Firms
(ACB, Acquisition, Acreage Holdings, ACRGF, Advertising, Akerna, APHA, Aphria Inc., Aurora Cannabis Inc., AXIM, AXIM Biotechnologies, Beverage, Biotechnology, Brand Development, Branding, Brazil, California, Cannabis, Cannabis and Hemp, Cannabis Capital Corp, CBCA, CBD, CGC, Colorado, Compliance, Consultants, Consulting, Consulting Services, CV Sciences, CVSI, Development, Distribution, Edibles, Education, Events, Extraction, Food, Growing, Hemp, Hemp, Inc., HEXO, iAnthus, Iconic Brands Inc., Investment, Investors, ITHUF, Jordan, KERN, KSHB, KushCo, Legalization, Lighting, Management, Manufacturing, Marketing, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, Michigan, MJNA, NEPT, Neptune Wellness, New York, OTC:HEMP, Packaging, Partnerships, Processing, Product Development, Production, Products, Research, Satori Resources, Inc., Scotts Miracle-Gro, Seed to Sale, SLANG Worldwide, SLNG, SMG, Social Media, South Africa, STRRF, Terra Tech Corp, Training, TRTC, United States, Vertically Integrated, Washington, THC, Web Design, Extracts, Financial Services, Pharmaceuticals, Cultivation, Funding, Hedge Fund, Holding Company) The cannabis industry is one of the most unique and restricted industries in general, but when it comes to advertising, marketing and public relations, it stands alone in its capabilities and the landscape in which to operate. The keys to any good marketing or PR campaign in cannabis, since advertising is still almost completely illegal to even engage, are creativity, understanding the laws, and relationships. If you have never worked in PR for the cannabis industry, and made the transition into it, you would know there is a learning curve that requires time. No matter how big, long standing or respected a firm may be, it will take 6-12 months to figure out how to navigate the cannabis terrain. Unfortunately, many brands and companies will go and hire the most expensive PR firm in the world, only to find out 3-6 months in, that they would have received 20 times more coverage if they would have gone with a firm that has a sole, or major, focus on cannabis for no less than a year...
https://www.greenmarketreport.com/2020-top-11-most-effective-cannabis-pr-firms/
02/18/2020 - 6:00am
AXIM, HEXO, OTC:HEMP, ACB, ACRGF, CBCA, TRTC, APHA, MJNA, CGC, CVSI, EXL, SLNG, ITHUF, KERN, KSHB, NEPT, SMG, STRRF
2020 Top 12 Most Effective Cannabis PR Firms
(ACB, Acquisition, Acreage Holdings, ACRGF, Advertising, Akerna, APHA, Aphria Inc., Aurora Cannabis Inc., AXIM, AXIM Biotechnologies, Beverage, Biotechnology, Brand Development, Branding, Brazil, California, Cannabis, Cannabis and Hemp, Cannabis Capital Corp, CBCA, CBD, CGC, Colorado, Compliance, Consultants, Consulting, Consulting Services, CV Sciences, CVSI, Development, Distribution, Edibles, Education, Events, EXL, Extraction, Florida, Food, Growing, Hemp, Hemp, Inc., HEXO, iAnthus, Iconic Brands Inc., Investment, Investors, ITHUF, Jordan, KERN, KSHB, KushCo, Law, Legalization, Lighting, Management, Manufacturing, Marketing, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, Michigan, MJNA, NEPT, Neptune Wellness, New York, OTC:HEMP, Packaging, Partnerships, Pennsylvania, Processing, Product Development, Production, Products, Research, Satori Resources, Inc., Scotts Miracle-Gro, Seed to Sale, SLANG Worldwide, SLNG, SMG, Social Media, South Africa, STRRF, Terra Tech Corp, Training, TRTC, United States, Vertically Integrated, Washington, THC, Web Design, Extracts, Financial Services, Pharmaceuticals, Cultivation, Funding, Hedge Fund, Holding Company) The cannabis industry is one of the most unique and restricted industries in general, but when it comes to advertising, marketing and public relations, it stands alone in its capabilities and the landscape in which to operate. The keys to any good marketing or PR campaign in cannabis, since advertising is still almost completely illegal to even engage, are creativity, understanding the laws, and relationships. If you have never worked in PR for the cannabis industry, and made the transition into it, you would know there is a learning curve that requires time. No matter how big, long standing or respected a firm may be, it will take 6-12 months to figure out how to navigate the cannabis terrain. Unfortunately, many brands and companies will go and hire the most expensive PR firm in the world, only to find out 3-6 months in, that they would have received 20 times more coverage if they would have gone with a firm that has a sole, or major, focus on cannabis for no less than a year...
https://www.greenmarketreport.com/2020-top-12-most-effective-cannabis-pr-firms/
02/14/2020 - 7:53am
Khiron to Participate in 3rd Annual Gravitas Growth Conference in Vancouver, BC
(Brazil, Canada, Cannabis, CBD, Colombia, Compliance, Distribution, Edibles, Education, Events, Investing, Law, Medical Marijuana, Mexico, Production, Products, Regulations, Regulatory Compliance, Testing, United States, Vertically Integrated, THC, Cultivation) Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN , OTCQB:KHRNF, Frankfurt:A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, is pleased to announce it will be participating in the 3rd Annual Gravitas Growth Conference taking place February 20th, 2020 at the Fairmont Pacific Rim Hotel in Vancouver, BC. DATE: February 20th, 2020 TIME: 2:55 pm PT FORMAT: Cannabis Industry Panel with Chris Naprawa, Khiron President LOCATION: Fairmont Pacific Rim Hotel, 1038 Canada Place, Vancouver, BC. Mr. Naprawa will also host individual investor meetings on February 20th at this year’s Gravitas Growth Conference, which will feature approximately 20 companies and will be attended by over 250 individuals. For additional details about the conference and Gravitas Securities Inc., please visit: www.gravitassecurities.com Recent Company Highlights Khiron prepares for imminent medical cannabis sales in Colombia, and to serve the unmet needs in a country...
https://investingnews.com/daily/cannabis-investing/khiron-to-participate-in-3rd-…
02/13/2020 - 6:54pm
Spain: U.S. Export Hotbed
(Belgium, Brazil, Canada, Growing, Hong Kong, Mexico, Products, Spain, United States, Power Systems, Pharmaceuticals, Security) It is surprising to those of us who have spent meaningful time in the country, but Spain is often overlooked as a business destination. Part of that has to do with the country’s ongoing problem with unemployment , which clouds outsider perceptions. Recent turmoil in Catalonia has not helped, with the optics at times making Barcelona seem like a Mediterranean Hong Kong. Yet Spain’s economy is the fourth-largest in the European Union and the 13th largest in the world . To put this in context, its economy is larger than Mexico’s. The country was one of the few bright spots in a generally lackluster Q4 in Europe. As for Catalonia, its economy is growing much faster than Spain’s as a whole. The U.S. is Spain’s most important partner outside Europe. In the first 11 months of 2019, the U.S. was Spain’s sixth-largest export and fifth-largest import partner . During that same period, exports to Spain from the United States grew at a faster clip than exports to any of the top 30 U.S. trade...
http://feedproxy.google.com/~r/cannalawblog/aogT/~3/uxbow3KhsXQ/
02/13/2020 - 12:00pm
CPH
Medical Cannabis Exports in Colombia Promise Massive Market Potential
(Australia, Brazil, Canada, Cannabis, Cannabis and Hemp, CBD, Colombia, CPH, Creso Pharma, Development, Distribution, Ecuador, Extraction, Facilities, Food, Germany, Greenhouses, Growers, Growing, Growing Facilities, Hemp, Investment, Investors, Law, Manufacture, Medical Marijuana, Oils, Peru, Pharmaceutical Grade, Portugal, Processing, Production, Products, Regulations, Research, Subsidiaries, United States, THC, Soil, Extracts, Pharmaceuticals, Cultivation, Security) International cannabis companies are rushing to Colombia, attracted by the country’s relatively advanced regulation, beefed-up security, cheap production costs and perfect weather conditions with many companies already anticipating growing exports of medical cannabis beginning this year.Unlike many countries in the region that only recently approved the clinical use of cannabis (like Perú), Colombia is further along the track after approving its regulatory framework in July 2016, which sets rules for the production, distribution, sale and export of seeds as well as derivative cannabis products.With the passage of Law 1787, Colombia joined the more than a dozen countries that have put into practice different types of regulation to explore the advantages of this plant as an alternative pharmaceutical, Rodrigo Arcila, president of the Colombian Cannabis Association (Asocolcanna), said.Clever LeavesGreenhouse-grown medical cannabis in Colombia.“Colombia will be a world leader in cannabis...
http://www.cannabisbusinesstimes.com/Article/colombia-medical-cannabis-exports-r…
02/13/2020 - 10:01am
MJNA
Medical Marijuana, Inc. (MJNA) Portfolio Investment Company Kannalife, Inc. Announces Completion of NIH-NIDA
(Argentina, Biotechnology, Brazil, California, Cannabis, CBD, Development, Events, Food, Hemp, Investment, Investments, Investors, Management, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Paraguay, Pennsylvania, Products, Research, Stocks, United States, Industrial Hemp, Pharmaceuticals) Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Announces Completion of NIH-NIDA Phase 1 Grant and Results from Temple University Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its portfolio investment company Kannalife, Inc. (“Kannalife”) (OTC: KLFE), a biopharmaceutical company specializing in the research and development of cannabinoid therapeutics, has completed its phase 1 study funded by a grant (1R41DA044898-01) from the National Institutes of Health’s (NIH) National Institute on Drug Abuse (NIDA). The study was performed by Kannalife and the Lewis Katz School of Medicine at Temple University (LKSOM) to assess KLS-13019, Kannalife’s patented cannabidiol (CBD)-like molecule, as a potential treatment of neuropathic pain and drug dependence. “KLS-13019 continues to...
https://marijuanastocks.com/mjna-portfolio-investment-company-kannalife-inc-anno…
02/11/2020 - 9:25am
MJNA
 Medical Marijuana, Inc. (MJNA) Flagship CBD Oil RSHO-X™ Clinical Study Results Show Promise
(Argentina, Brazil, California, Cannabis, CBD, Compliance, Development, Events, Food, Hemp, Investment, Investments, Investors, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Paraguay, Products, Research, Stocks, United States, Industrial Hemp, Pharmaceuticals) Medical Marijuana, Inc. Flagship CBD Oil RSHO-X Clinical Study Results Show Promise Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that a clinical study conducted in Mexico using its Real Scientific Hemp Oil-X cannabidiol (CBD) oil has been completed and published in the EC Neurology (ECNE), an internationally peer-reviewed journal that publishes articles related to worldwide research in neuroscience. “We are encouraged by the study’s results and look forward to understanding more about CBD’s potential effects as we continue to conduct research on this topic,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “There are many people who are already using our products to experience a variety of health and wellness benefits. We believe that with the added assurance of these results, there will be...
https://marijuanastocks.com/mjna-flagship-cbd-oil-rsho-x-clinical-study-results-…
02/10/2020 - 12:50pm
Khiron's Medical Cannabis Products Approved For Import Into Brazil - Benzinga
(Brazil, Cannabis, Medical Marijuana, Products) Khiron's Medical Cannabis Products Approved For Import Into Brazil Benzinga
https://www.benzinga.com/markets/cannabis/20/02/15289172/khirons-medical-cannabi…
02/07/2020 - 9:25am
Brazil Health Agency Authorizes Import of Khiron Medical Cannabis Product - The DMO
(Brazil, Cannabis, Medical Marijuana) Brazil Health Agency Authorizes Import of Khiron Medical Cannabis Product The DMO
https://mjobserver.com/investments/brazil-health-agency-authorizes-import-of-khi…
02/07/2020 - 8:46am
Brazil Health Agency Authorizes Import of Khiron Medical Cannabis Product
(Brazil, Cannabis, Medical Marijuana) Khiron Life Sciences Corp. announced that the Brazilian Health Regulatory Agency... The post Brazil Health Agency Authorizes Import of Khiron Medical Cannabis Product appeared first on The Daily Marijuana Observer .
https://mjobserver.com/investments/brazil-health-agency-authorizes-import-of-khi…
02/07/2020 - 8:13am
Brazil Health Agency Authorizes Import of Khiron Medical Cannabis Product | INN - Investing News Network
(Brazil, Cannabis, Investing, Medical Marijuana) Brazil Health Agency Authorizes Import of Khiron Medical Cannabis Product | INN Investing News Network
https://investingnews.com/daily/cannabis-investing/brazil-health-agency-authoriz…
02/07/2020 - 7:37am
Brazil Health Agency Authorizes Import of Khiron Medical Cannabis Product - Yahoo Finance
(Brazil, Cannabis, Medical Marijuana) Brazil Health Agency Authorizes Import of Khiron Medical Cannabis Product Yahoo Finance
https://finance.yahoo.com/news/brazil-health-agency-authorizes-import-123700602.…
02/06/2020 - 9:37am
The Latest CBD Research: Q&A with Alice O’Leary-Randall
(Brazil, Cannabis, CBD, CBG, Germany, Growing, Hemp, Israel, Medical Marijuana, Recreational, Research, Science, THC, Dispensaries) The CBD industry’s explosive growth is quickly outpacing science, but with the passage of the 2018 Farm Bill, research has begun in earnest, and more is being known about the benefits of this now common cannabis compound and its uses.Alice O’Leary-Randall has been on the forefront of the medical cannabis movement ever since her late husband, Robert C. Randall, became the first person in the U.S. to legally receive medical cannabis. Now the editor-in-chief of Mary’s Medicinals publications, O’Leary-Randall frequently writes and speaks on the issue. Here, she outlines some common CBD myths, as well as what current research suggests about the therapeutic properties of CBD, drug-to-drug interactions and best clinical practices for medical professionals.Cannabis Business Times: What are some common CBD myths that have been dispelled through research?Alice O’Leary-Randall: I think the most common one that I hear is that you can use CBD because that way you won’t fail the drug test at work...
http://www.cannabisbusinesstimes.com/Article/the-latest-cbd-research-alice-olear…
02/06/2020 - 9:18am
MJNA
Medical Marijuana, Inc. (MJNA) Subsidiary Kannaway® Welcomes Renowned Wellness Expert
(Argentina, Brazil, California, Cannabis, CBD, Development, Events, Food, Hemp, Investment, Investments, Investors, Management, Marketing, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Paraguay, Products, Research, Science, Stocks, United States, Industrial Hemp, Pharmaceuticals) Medical Marijuana, Inc. Subsidiary Kannaway® Welcomes Renowned Wellness Expert and Certified Nutrition Coach Daniel Miller as Company Spokesperson Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that renowned wellness expert and Certified Nutrition Coach Daniel Miller has joined its subsidiary Kannaway®. Miller, in partnership with Kannaway® as their new spokesperson, has created the world’s first cannabis fitness program and is developing a new fitness-based product line to support that program. “Kannaway aims to provide consumers from all areas of life around the world with the highest-quality wellness products that are tailored to fit their lifestyles,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “This partnership with Daniel Miller will allow us to better serve our wellness-minded...
https://marijuanastocks.com/mjna-subsidiary-kannaway-welcomes-renowned-wellness-…
02/05/2020 - 8:25am
PNTV
 Player’s Network, Inc. (PNTV) Shareholder 2019 Year in Review and 2020 Outlook
(Acquisition, Argentina, Beverage, Brazil, Canada, Cannabis, CBD, CBG, CBN, Compliance, Consumer Products, Development, Distribution, Events, Extraction, Facilities, Genetics, Greenhouses, Grow Lights, Growers, Growing, Hemp, Investments, Investors, Joint Ventures, Legalization, Management, Marketing, Media, Medical Marijuana, Nevada, New York, Oils, Players Network, PNTV, Processing, Production, Products, Quality Control, Recreational, Regulations, Stocks, Tracking, United States, Uruguay, Vertically Integrated, Videos, Lights, THC, Dispensaries, Extracts, Pharmaceuticals, Cultivation, Funding, Security) Players Network, Inc. Shareholder 2019 Year in Review and 2020 Outlook Player’s Network, Inc. (OTCPINK:PNTV), a rapidly growing international company in the adult-use and medical marijuana industry, with operations in Las Vegas, Nevada and Jujuy Argentina, published a Shareholder update from CEO Mark Bradley. Please visit this link https://playersnetwork.com/2019-year-in-review/ to view the full 2019 Shareholder Update with images and videos. Dear Shareholder, 2019 was, as Dickens said, the worst of times and the best of times. It was a year of struggles. It was also a year of great accomplishments. We laid tremendous groundwork for the future prosperity of our company. Let’s address our struggles and accomplishments. After 28 years as a fully reporting public company, we struggled to get our 2018 and 2019 audits and financial statements current due to unprofessional conduct by our prior accounting firm, forcing us to sue them for damages. We are targeting the end of Q1 2020 to get...
https://marijuanastocks.com/pntv-shareholder-2019-year-in-review-and-2020-outloo…
02/04/2020 - 10:07am
MJNA
 Medical Marijuana, Inc. (MJNA) Subsidiary HempMeds® Brasil Announces New Chief Medical Officer
(Argentina, Brazil, California, Cannabis, CBD, Development, Education, Events, Food, Hemp, Investment, Investments, Investors, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Paraguay, Products, Research, Stocks, United States, Industrial Hemp, Pharmaceuticals) Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Announces New Chief Medical Officer Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® Brasil has appointed Dr. Rubens Wajnsztejn as the Company’s Chief Medical Officer. “More than just someone who believes in the power of cannabidiol (CBD), Dr. Wajnsztejn is an expert researcher and has direct contact with many Brazilian doctors and future health professionals who need to be educated on this compound’s potential wellness benefits,” said HempMeds® Brasil Vice President Caroline Heinz. “He will be joining our team to help us further establish relationships with hospitals and medical practices throughout Brazil and oversee studies to test the safety and efficacy of our products.” Dr. Wajnsztejn is a neuropediatric...
https://marijuanastocks.com/mjna-subsidiary-hempmeds-brasil-announces-new-chief-…
02/02/2020 - 10:31pm
Cannabis Sustainability: Hemp Perspectives
(Argentina, Brazil, California, Canada, Cannabis, Cannabis and Hemp, Chile, Colombia, Colorado, Consulting, Containers, Development, Education, Extraction, Fabric, Florida, Food, France, Greenhouses, Growing, Hemp, Hemp Plastic, Hemp Products, Law, Legalization, Management, Manufacture, Manufacturing, Medical Marijuana, Monitoring, Organic, Packaging, Pesticide, Processing, Production, Products, Regulations, Research, Strains, Synthetic, Synthetic Cannabis, United States, Uruguay, Industrial Hemp, Soil, Pharmaceuticals, Cultivation, Security) In my previous Medics Series, I tackled the tip of the iceberg on this prescient issue facing cannabis companies across the states when I asked the question: “What about sustainability in the Florida cannabis industry? On the topic of sustainability, Florida also currently lacks a dedicated patient or clinic “cannabis collection” station for used cannabis products; an integrated program for safe disposal here in Florida must be addressed, by the Medical Marijuana Advisory Committee or other dedicated state body. For example a patient-safe, secure system of cannabis disposal could operate within Florida in the same manner as the plethora of statewide “no questions asked” needle disposal/exchange programs currently offered to the general public. Or similarly, a state cannabis collection program could operate county or city-wide, like the popular unused or expired medication collections that occur on a regular basis throughout the United States in an effort to keep these pharmaceuticals...
https://cannabislaw.report/cannabis-sustainability-hemp-perspectives/
01/29/2020 - 6:14am
MJNA
Medical Marijuana, Inc. Subsidiary Kannaway® Expands Into Russia, Kazakhstan and Kyrgyzstan
(Argentina, Brazil, California, Cannabis, CBD, Development, Events, Growing, Hemp, Investment, Kazakhstan, Kyrgyzstan, Marketing, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Nutraceuticals, Online Store, Paraguay, Products, Research, Russia, United States, Industrial Hemp, Pharmaceuticals) SAN DIEGO, Jan. 28, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® is now available in Russia, Kazakhstan and Kyrgyzstan. Kannaway® was the first direct selling company to offer hemp-derived cannabidiol (CBD) products in both the U.S. and Europe. The Company currently ships its products to over 30 countries in Europe and throughout the United States. In June 2019, Kannaway® announced its expansion into the Asian market and this expansion into Russia, Kazakhstan and Kyrgyzstan is part of the Company’s aggressive international expansion plans. “Kannaway has pioneered direct selling hemp-derived CBD in the U.S. and Europe and has been rapidly expanding as consumers in new markets are eager to try our products,” said Medical Marijuana, Inc. CEO Dr...
https://cannabislaw.report/medical-marijuana-inc-subsidiary-kannaway-expands-int…
01/29/2020 - 5:34am
Brazil's view on medical cannabis: time for a rethink? - Latin Lawyer
(Brazil, Cannabis, Medical Marijuana) Brazil's view on medical cannabis: time for a rethink? Latin Lawyer
https://latinlawyer.com/article/1213289/brazils-view-on-medical-cannabis-time-fo…
01/28/2020 - 1:19pm
MJNA
Medical Marijuana, Inc. (MJNA) Subsidiary Kannaway® Expands Into Russia
(Argentina, Brazil, California, Cannabis, CBD, Development, Events, Food, Growing, Hemp, Investment, Investments, Investors, Kazakhstan, Kyrgyzstan, Marketing, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Nutraceuticals, Online Store, Paraguay, Products, Research, Russia, Stocks, United States, Industrial Hemp, Pharmaceuticals) Medical Marijuana, Inc. Subsidiary Kannaway® Expands Into Russia, Kazakhstan and Kyrgyzstan Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® is now available in Russia, Kazakhstan and Kyrgyzstan. Kannaway® was the first direct selling company to offer hemp-derived cannabidiol (CBD) products in both the U.S. and Europe. The Company currently ships its products to over 30 countries in Europe and throughout the United States. In June 2019, Kannaway® announced its expansion into the Asian market and this expansion into Russia, Kazakhstan and Kyrgyzstan is part of the Company’s aggressive international expansion plans. “Kannaway has pioneered direct selling hemp-derived CBD in the U.S. and Europe and has been rapidly expanding as consumers in new markets are eager to try...
https://marijuanastocks.com/mjna-subsidiary-kannaway-expands-into-russia/
01/28/2020 - 6:26am
MXC
Australia: MGC to distribute medical cannabis in South America
(Australia, Brazil, Cannabis, Distribution, Erin Resources Limited, Ireland, Medical Marijuana, MGC Pharma, MXC, Peru, Products, Pharmaceuticals) ASX-listed medicinal cannabis company, MGC Pharmaceuticals, has inked a distribution agreement to produce and supply its cannabinoid medicines to South American based Anden Bio Naturals SA, a company that pioneered the legal import of cannabis-based products into Peru via a tender with its Government’s Ministry of Health. The exclusive five-year agreement will give MGC access to Anden’s Peruvian and Bolivian industry networks containing over 7,500 pharmacies, private clinics and an oncological private insurance system that has over one million listed clients. Co-founder and Managing Director of MGC Pharma, Roby Zomer said: “This closely follows our entry to the Latin American market in November 2019, when MGC Pharma’s products became available in Brazil and in December receiving formal approval for the sale of CannEpil in Ireland.” Read more at : https://thewest.com.au/business/public-companies/mgc-to-distribute-medical-cannabis-in-south-america-c-669094
https://cannabislaw.report/australia-mgc-to-distribute-medical-cannabis-in-south…
01/17/2020 - 5:49pm
The Brazil Tech And Innovation Roundup: Cannabis Firms Wanted - Forbes
(Brazil, Cannabis) The Brazil Tech And Innovation Roundup: Cannabis Firms Wanted Forbes
https://www.forbes.com/sites/angelicamarideoliveira/2020/01/17/the-brazil-tech-a…
01/17/2020 - 6:26am
New Study: CBD May Ease Public Speaking Fears—And Lead to a Better Parkinson's Drug
(Brazil, CBD) A big fat dose of CBD ought to quell your qualms just fine, a new study out of Brazil suggests. However, there's one large caveat: The findings are ...
https://observer.com/2020/01/cbd-anxiety-tremors-parkinsons-patients-study/&ct=g…
01/14/2020 - 5:29pm
Extension meeting set to host Winter Hemp Meeting - Brazil Times
(Brazil, Hemp) Extension meeting set to host Winter Hemp Meeting Brazil Times
http://www.thebraziltimes.com/story/2661507.html
01/11/2020 - 9:24pm
SPRWF
SUPREME CANNABIS ANNOUNCES LEADERSHIP TRANSITION
(Brazil, Canada, Cannabis, Consumer Goods, Growing, Management, Manufacturing, Marketing, Mexico, Processing, Product Testing, Production, Products, Recreational, SPRWF, Strains, Testing, Cultivation) Supreme Cannabis Board Director and former President of Starbucks Coffee Canada, Colin Moore, appointed Interim President and CEO. Navdeep Dhaliwal departs Company, effective immediately. Interim CEO to leverage successful track record to accelerate growth and transformation strategy, while improving speed to market and rightsizing operating and capital spends. Search for new CEO to begin immediately. TORONTO, Jan. 6, 2020 /CNW/ – The Supreme Cannabis Company, Inc. (“Supreme Cannabis” or the “Company“) (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) announced today its Board of Directors (the “Board“) has named Colin Moore, Director of the Company and former President of Starbucks Coffee Canada, as Interim President and Chief Executive Officer, effective immediately. Mr. Moore succeeds Navdeep Dhaliwal, who has departed the Company. The Company is in the process of engaging a leading, nationally recognized search firm to identify and evaluate a new CEO to lead Supreme Cannabis in its next...
https://cannabislaw.report/supreme-cannabis-announces-leadership-transition/